P-24. Seven Versus Fourteen Days of Antibiotics for Gram-Negative Bacteremia from a Urinary Tract Source:A Systematic Review and Meta-Analysis
Abstract
Abstract Background The optimal duration of antibiotic therapy for gram-negative bacteremia sourced from urinary tract infections (UTI) remains uncertain. We performed a systematic review and meta-analysis comparing short-course (approximately 7 days) versus prolonged-course (approximately 14 days) antibiotic therapy in this population.Figure 1: Forest plot of outcomesTable 1: Study design Methods We systematically searched PubMed, Embase, and ClinicalTrials.gov through April 26, 2025. Studies were included if they compared 7-day versus 14-day antibiotic therapy in gram-negative bacteremia with ≥65% UTI source or performed a dedicated UTI subgroup analysis. Outcomes assessed included 30- and 90-day mortality and recurrence rates. Risk ratios (RR) were pooled using a random-effects model. Noninferiority was assessed using a prespecified margin of RR 1.25, and superiority was assessed with a threshold of RR < 1.00. Results Six studies (three randomized trials, three observational cohorts) encompassing 4,448 patients were included. There were no significant differences between short- and prolonged-course therapy for 30-day mortality (RR 0.97, 95% CI 0.64–1.47; p=0.90), 30-day recurrence (RR 1.38, 95% CI 0.80–2.37; p=0.24), 90-day mortality (RR 0.90, 95% CI 0.77–1.06; p=0.20), or 90-day recurrence (RR 0.68, 95% CI 0.45–1.01; p=0.06). Conclusion Our findings suggest that a 7-day course may be sufficient for most patients with UTI-sourced gram-negative bacteremia. Disclosures All…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 4,448 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.